查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1848567

胃食道逆流症治疗设备市场（依产品类型、最终用户和通路划分）－2025-2032年全球预测

Gastroesophageal Reflux Disease Devices Market by Product Type, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，胃食道逆流治疗设备市场规模将达 190.4 亿美元，复合年增长率为 14.05%。

关键市场统计数据
基准年 2024 66.5亿美元
预计年份：2025年 75.8亿美元
预测年份 2032 190.4亿美元
复合年增长率 (%) 14.05%

全面审视不断发展的胃食道逆流症（GERD）器材领域，以及推动快速创新的临床和商业性因素。

胃食道逆流症仍然是一种具有重要临床意义的疾病，它持续推动内视镜、磁振造影、射频和外科手术等治疗方法的创新和器械研发。临床医生和医疗系统日益寻求能够减少长期药物依赖、最大限度降低手术全期风险并实现当日治疗的治疗方法。因此，医疗设备领域呈现出快速迭代、更加重视以病人为中心的治疗效果以及门诊病人优化技术的涌现等特点。

同时，支付方的审查和医院的采购週期正在影响医疗器材的普及速度，对安全性和耐用性的临床证据要求也日益严格。从住院治疗转向门诊手术中心和专科诊所，迫使医疗器材製造商提供紧凑、经济高效且可互通的系统，以便与现有的手术室技术体系整合。因此，商业和临床领导者必须应对这样的环境：技术前景必须与可重复的临床表现和可行的报销策略相符。

深入分析影响胃食道逆流（GERD）器材应用和医疗服务提供者决策的临床、技术和商业性变革

胃食道逆流治疗器械领域正经历一场变革，其驱动力主要来自手术方式的改变，包括微创手术平台的兴起、磁性括约肌加固理念的成熟以及经口和内镜缝合技术的改进。临床医生正致力于在控制症状和保留解剖结构之间寻求平衡，而器械研发人员则不断迭代改进，优先考虑器械的易用性、可重复性和降低术后併发症发生率。

此外，随着机器人辅助和增强成像技术的出现，外科胃底折迭术也在不断发展；射​​频消融系统则透过导管设计和能量传输精度的提升而脱颖而出。这些技术进步与医疗保健系统的发展趋势同步进行，例如门诊服务的扩展、基于价值的合约模式以及对健康经济学的关注。因此，市场参与企业被迫将临床证据的产生与使用者培训计画结合，并重新设计其商业模式，以支持包括独立门诊中心、医院附属机构和专科诊所在内的各类终端使用者。因此，那些能够将工程敏捷性与强大的临床检验和适应性市场策略相结合的机构，将在这一变革时期过程中占据优势。

对 2025 年生效的美国累积关税将如何重塑供应链、采购行为和医疗设备商业化策略进行策略分析。

自2025年起生效的美国新关税的累积效应正在重塑整个胃食道逆流症医疗器材生态系统的供应链策略、零件采购决策和定价动态。依赖进口特种零件（例如精密导管、磁性材料和微电子元件）的医疗器材製造商正面临更高的到岸成本，这促使他们重新评估材料成本优化策略，并加快对国内或近岸供应商的评估。因此，采购团队正在优先考虑双重采购、签订长期供应商合约以及增加库存缓衝，以降低成本波动和前置作业时间不确定性。

此外，关税主导的成本压力正在影响市场竞争策略。有些製造商选择自行承担成本上涨以维持价格竞争力，而有些製造商则推出差异化的服务组合以保障利润。医院和门诊手术中心正在透过加强资本配置审查并要求医疗设备供应商提供更清晰的「总医疗成本」会计来应对这项挑战。关税环境也促使企业投资于本地组装和测试能力，这可以减轻进口关税的影响，并缩短产品迭代的监管申报时间。最后，支付方和医疗系统正在密切关注这些动态，并日益将报销讨论与可证明的价值和长期成本抵消联繫起来，而不仅仅是考虑产品的领先价格。

提供可操作的细分洞察，揭示产品架构、临床环境和通路如何影响竞争定位和市场接受度动态。

细分市场层面的动态变化揭示了产品类型、终端用户和通路之间的有效差异化，直接影响产品开发重点和商业规划。就产品类型而言，内视镜缝合器材正在不断发展，竞争的缝合系统和成熟的平台（如Overstitch）优先考虑更小的输送尺寸和更高的组织缝合一致性。射频消融器械的定位则取决于先进的导管系统，后者强调病灶控制和能量调节，而标准导管系统则强调成本和易用性。在外科腹腔镜成形术领域，传统的腹腔镜系统正被机器人辅助腹腔镜系统所取代，后者提供了更高的灵活性和更清晰的视野。经口、无切口腹腔镜成形术平台（例如Esophyx系统和新一代腹腔镜成形术解决方案）的竞争主要体现在手术时间、解剖修復的持久性和门诊病人的可及性。

终端用户细分进一步细化了购买行为和临床路径。门诊手术中心（包括独立中心和医院附属中心）倾向于选择支持短期住院或当日出院通讯协定并最大限度减少资本投入的设备。诊所，包括基层医疗和专科医院，倾向于在手术量和训练能力之间取得平衡，而专科胃肠病中心和多学科中心则优先考虑不同的手术组合和术后支持模式。分销管道细分錶明，直销仍然是高触感设备推广的首选途径，而透过电子商务平台和製造商入口网站进行的线上销售在耗材和辅助工具方面正在增长，全国性和区域性第三方分销商在扩大产品覆盖范围至各种临床环境方面继续发挥关键作用。综上所述，这些细分洞察表明，製造商必须根据每个使用者群体独特的经济和业务限制来调整其产品功能、培训计划和通路策略。

关键区域洞察，阐述美洲、欧洲、中东和非洲以及亚太地区的市场动态将如何影响监管、临床和供应链策略。

区域动态对美洲、欧洲、中东和非洲以及亚太市场的监管路径、临床应用模式和供应链韧性有显着影响。在美洲，强大的医院网络和日益增多的门诊手术中心倾向于选择具有已证实的门诊疗效和可靠临床证据的医疗设备，而采购週期和支付方谈判则更侧重于降低整体医疗成本。该地区也是下一代系统早期商业化推出的中心，其临床效用由临床专家和学术中心检验。

在中东和非洲，监管体系的多样性和报销框架的碎片化意味着打入市场策略必须根据各国的具体临床指南和采购惯例量身定制。专科中心，尤其是那些专注于微创手术的中心，可以透过制定符合卫生经济学评估和真实世界证据的价值檔案来加速市场进入。在亚太地区，医疗基础设施的快速投资以及训练有素的内视镜医师和外科医生队伍的不断壮大，推动了人们对高性价比技术和可扩展培训模式的兴趣。此外，该地区的製造和组装中心是寻求供应链多元化和降低进口关税影响的企业的重要战略支柱，而本地临床试验以及与区域意见领袖的伙伴关係可以显着促进技术的推广应用。

决定胃食道逆流（GERD）器材市场竞争优势的关键公司层级因素包括平台策略、伙伴关係、临床证据和售后服务。

胃食道逆流症医疗器材市场的竞争格局受到多方因素的影响，包括成熟的医疗设备製造商、专注于平台扩充性和临床整合的专业新兴企业以及跨学科技术合作伙伴。大型公司正投资于模组化平台策略，以实现功能增量升级而无需彻底改造硬件，从而缩短产品迭代周期并减轻监管负担。同时，规模较小的创新者正透过解决特定的临床痛点，例如缩小设备体积、简化部署流程和改善术后监测，来开闢利基市场。

为了将临床信誉与商业规模相结合，企业普遍采取策略联盟和选择性收购的方式，而售后服务（例如，手术培训、指导和一次性耗材项目）作为收入和客户维係手段的重要性也日益凸显。智慧财产权组合和临床证据的深度是影响医院处方决策和支付方谈判的关键差异化因素。最后，整合了数位健康功能、患者报告结果追踪和远端追踪工具的企业更有可能与寻求综合护理路径而非独立设备的医疗系统签订长期合约。

为领导者提供有针对性的实用建议，以加强供应链、证据收集、培训计划和商业模式，从而加速产品推广并确保获利。

产业领导者应优先采取一系列切实可行、注重执行的措施，以应对当前的挑战并抓住新的机会。首先，应考虑实现零件采购多元化，并将关键子次组件流程外包至近岸地区，以降低关税风险并减少前置作业时间波动。在增强供应链韧性的同时，应投资以产生符合支付方终点和医院价值框架的临床证据，并专注于耐用性、生活品质和成本抵消分析，以支持门诊和医院的推广应用。

第二，我们将设计培训和指导项目，以降低学习曲线，实现快速规模化，并扩展在门诊手术中心和专科诊所的应用场景。第三，我们将采用灵活的商业模式，结合电子商务和经销商奖励销售耗材和配件，并辅以直销以实现高高触感率，同时协商捆绑定价和订阅模式，使激励机制与长期成果保持一致。第四，我们将加速开发下一代设备功能，例如核磁共振安全材料、可调式磁性结构和先进的导管控制技术，以使我们的产品蓝图脱颖而出。第五，我们将积极与监管机构和支付方沟通，简化医保覆盖流程，并推动其纳入临床指南。最后，我们将针对价格调整和报销政策变化进行情境规划，以确保定价的灵活性，并持续投入研发和临床医生参与。

透明严谨的调查方法，结合了一手资料和二手资料研究。调查方法融合了与临床医生和采购负责人的访谈、二手临床和监管研究以及供应链分析。

本分析的调查方法结合了结构化的初步研究、严谨的二次综合分析和迭代检验，以确保其可靠性和实用性。初步研究包括对临床医生、采购负责人、供应链经理和行业高管进行结构化访谈，以了解设备在实际应用中的表现、推广障碍和采购偏好。二次研究包括对同行评审的临床文献、监管文件、手术编码指南和公开的技术摘要进行系统性回顾，以梳理设备功能集和临床终点。

透过将访谈内容与监管文件和製造商的技术规范进行交叉比对，实现了资料三角验证。供应链图谱利用贸易流量、零件采购模式和生产布局分析，解读了关税和物流限制的影响。品管包括临床专家和方法学家的同行评审、分歧的协调以及假设的透明记录。鑑于存在区域数据缺口或长期耐久性证据尚不成熟等局限性，该报告建议随着更多真实世界证据的出现和监管决策的製定，定期更新报告。

结论的全面总结强调了将临床证据、供应链韧性和适应性商业化相结合，以引领胃食道逆流（GERD）器材的普及应用至关重要。

摘要，受技术进步、门诊治疗模式转变以及支付方期望变化等因素驱动，胃食道逆流症器械市场正处于曲折点。那些能够平衡产品研发与临床价值验证、投资完善的培训和售后服务项目并建立稳健供应链的开发商，将更有利于充分利用微创、以门诊病人为主的治疗路径转变带来的机会。关税环境的累积和区域监管差异虽然增加了市场的复杂性，但也为企业回流和建立策略伙伴关係关係创造了奖励，从而带来竞争优势。

最终，成功与否取决于能否将临床前景转化为可复製的成果，能否向支付方和医疗服务提供方清晰地阐明价值提案，以及能否实施一种适应性强的商业模式，以反映门诊手术中心、诊所和医院的运作方式。相关人员，将引领下一波技术应用浪潮，并塑造长期的医疗服务标准。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 使用磁性括约肌增强装置取代长期PPI治疗
  • 透过将即时电阻pH监测导管与无线数据分析结合，实现个人化逆流管理
  • 开发一种经口无切口胃底折迭术系统，并增强其内视镜缝合功能
  • 推广可生物降解支架技术，以最大程度减少难治性胃食道逆流症患者的併发症
  • 远端患者监护平台对胃底折迭术后胃食道逆流症治疗长期疗效的影响
  • 利用新型超音波导引球囊系统进行酸袋标靶治疗的疗效
  • 以患者为中心的数位健康应用程式在症状追踪和人工智慧驱动的治疗建议方面取得了成长

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 胃食道逆流症治疗设备市场（依产品类型划分）

  • 内视镜缝合器械
    • 竞争性缝合系统
    • 包缝系统
  • 磁性括约肌增强装置
    • 第一代系统
    • 下一代系统
  • 射频消融术装置
    • 高阶导管系统
    • 标准导管系统
  • 外科胃底折迭装置
    • 传统腹腔镜系统
    • 机器人辅助腹腔镜系统
  • 经口无切口胃底折迭装置
    • Ethofix Systems
    • 下一代胃底折迭术系统

9. 依最终用户分類的胃食道逆流症治疗设备市场

  • 门诊手术中心
    • 独立中心
    • 医院相关中心
  • 诊所
    • 基层医疗诊所
    • 专科诊所
  • 医院
    • 综合医院
    • 专业中心
      • 消化系统专科中心
      • 多专科中心

第十章 胃食道逆流症治疗器材市场（依分销管道划分）

  • 直销
  • 线上销售
    • 电子商务平台
    • 製造商门户
  • 第三方经销商
    • 全国经销商
    • 区域经销商

第十一章 各地区胃食道逆流症治疗器材市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 胃食道逆流症治疗器材市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国胃食道逆流症治疗器材市场概况

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Johnson & Johnson
    • Medtronic plc
    • Boston Scientific Corporation
    • Olympus Corporation
    • Becton, Dickinson and Company
    • Cook Medical LLC
    • Torax Medical, Inc.
    • Mederi Therapeutics, Inc.
    • EndoGastric Solutions, Inc.
    • GI Dynamics, Inc.
Product Code: MRR-925E8149CEF2

The Gastroesophageal Reflux Disease Devices Market is projected to grow by USD 19.04 billion at a CAGR of 14.05% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.65 billion
Estimated Year [2025] USD 7.58 billion
Forecast Year [2032] USD 19.04 billion
CAGR (%) 14.05%

A comprehensive introduction to the evolving gastroesophageal reflux disease device landscape and the clinical and commercial forces driving rapid innovation

Gastroesophageal reflux disease remains a clinically significant condition that continues to shape procedural innovation and device development across endoscopic, magnetic, radiofrequency, and surgical approaches. Clinicians and health systems are increasingly seeking interventions that reduce long-term medication dependence, minimize perioperative risk, and enable same-day pathways. As a result, the device landscape is characterized by rapid iteration, a heightened focus on patient-centric outcomes, and the emergence of outpatient-optimized technologies.

In parallel, payer scrutiny and hospital procurement cycles are shaping adoption curves, while clinical evidence requirements for safety and durability are becoming more rigorous. Transitioning care away from inpatient admissions toward ambulatory surgical centers and specialized clinics is exerting pressure on device manufacturers to deliver compact, cost-effective, and interoperable systems that integrate with existing operating room technology stacks. Consequently, commercial and clinical leaders must navigate an environment where technological promise must be matched by reproducible clinical performance and viable reimbursement strategies.

An in-depth look at the transformative clinical, technological, and commercial shifts reshaping GERD device adoption and provider decision-making

The landscape for gastroesophageal reflux disease devices is undergoing transformative shifts driven by procedural migration to minimally invasive platforms, the maturation of magnetic sphincter augmentation concepts, and the refinement of transoral and endoscopic suturing techniques. Clinicians are adopting approaches that seek to balance symptom control with anatomical preservation, and device developers are responding with iterations that prioritize ease of deployment, reproducibility, and reduced periprocedural morbidity.

Moreover, surgical fundoplication is evolving through greater use of robotic assistance and enhanced imaging, while radiofrequency ablation systems are differentiating on catheter design and energy delivery precision. These technology advances are occurring alongside broader healthcare system trends such as outpatient care expansion, value-based contracting, and greater emphasis on health economics. Consequently, market participants are compelled to align clinical evidence generation with user training programs and to redesign commercial models to support diverse end users, including freestanding ambulatory centers, hospital-affiliated facilities, and specialty clinics. This period of transformation therefore favors organizations that couple engineering agility with robust clinical validation and adaptive go-to-market strategies.

A strategic analysis of how the cumulative United States tariffs introduced in 2025 are restructuring supply chains, procurement behaviors, and device commercialization strategies

The cumulative effects of new United States tariffs enacted in 2025 are reshaping supply chain strategies, component sourcing decisions, and pricing dynamics across the gastroesophageal reflux disease device ecosystem. Device manufacturers that rely on imported specialty components such as precision catheters, magnetic materials, or microelectronics are experiencing higher landed costs, prompting reassessment of bill-of-materials optimization and accelerated evaluation of domestic or nearshore suppliers. As a result, procurement teams are prioritizing dual-sourcing, longer-term supplier agreements, and increased inventory buffers to mitigate cost volatility and lead-time uncertainty.

In addition, tariff-driven cost pressures are influencing go-to-market choices, with some manufacturers electing to absorb incremental costs to preserve competitive pricing while others are introducing differentiated service bundles to maintain margin. Hospitals and ambulatory surgical centers are responding by intensifying capital allocation reviews and demanding clearer total-cost-of-care narratives from device vendors. The tariff environment is also catalyzing investment in localized assembly and testing capabilities, which reduces exposure to import duties and can shorten regulatory submission timelines for incremental device iterations. Finally, payers and health systems are watching these developments closely, increasingly tying reimbursement conversations to demonstrable value and long-term cost offsets rather than upfront device price alone.

Actionable segmentation insights revealing how product architectures, clinical settings, and distribution pathways influence competitive positioning and adoption dynamics

Segment-level dynamics reveal meaningful differentiation across product types, end users, and distribution avenues that directly inform product development priorities and commercial planning. Within product type segmentation, endoscopic suturing devices are evolving with competitive suturing systems and established Overstitch-like platforms prioritizing smaller-profile delivery and improved tissue apposition consistency, while magnetic sphincter augmentation offerings continue to advance from first generation designs toward next generation systems that focus on adjustability, MRI compatibility, and simplified implantation workflows. Radiofrequency ablation devices are being positioned through advanced catheter systems that emphasize lesion control and energy modulation versus standard catheter systems where cost and ease of use remain dominant considerations. In the surgical fundoplication space, conventional laparoscopic systems are increasingly complemented by robotic assisted laparoscopic systems that offer enhanced dexterity and visualization but require different capital and training commitments. Transoral incisionless fundoplication platforms, represented by entrenched Esophyx-like systems and emergent next generation fundoplication solutions, are competing on procedure time, durability of anatomical repair, and outpatient readiness.

End user segmentation further nuances purchasing behavior and clinical pathways. Ambulatory surgical centers, including both freestanding centers and hospital-affiliated centers, are gravitating toward devices that support short-stay or same-day discharge protocols and that minimize capital footprint. Clinics, whether primary care clinics or specialty clinics, are more selective in device adoption, often focusing on referral networks and diagnostic-to-procedure continuity. Hospitals, including general hospitals and specialty centers, tend to balance surgical volume considerations against training capacity, with gastroenterology specialty centers and multispecialty centers each prioritizing different procedural mixes and post-procedure support models. Distribution channel segmentation highlights that direct sales remain the preferred route for high-touch device adoption, whereas online sales through e-commerce platforms and manufacturer portals are growing for consumables and adjunct tools, and third party distributors, both national and regional, continue to play an essential role in extending reach into varied clinical settings. Collectively, these segmentation insights underscore the need for manufacturers to tailor product feature sets, training programs, and channel strategies to the specific economics and operational constraints of each buyer cohort.

Critical regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific market dynamics shape regulatory, clinical, and supply chain strategies

Regional dynamics materially influence regulatory pathways, clinical adoption patterns, and supply chain resilience across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. In the Americas, strong hospital networks and growing ambulatory surgical center capacity favor devices that demonstrate outpatient efficacy and robust clinical evidence, while procurement cycles and payer negotiations place emphasis on demonstrable reductions in total cost of care. This region also serves as a focal point for early commercial launches of next generation systems, where clinician champions and academic centers validate clinical utility.

In Europe Middle East & Africa, regulatory heterogeneity and fragmented reimbursement frameworks mean that market entry strategies must be tailored to country-specific clinical guidelines and procurement practices. Here, value dossiers that address health economic evaluations and real-world evidence can accelerate uptake, particularly in specialty centers that emphasize minimally invasive care. In the Asia-Pacific region, rapid investment in healthcare infrastructure and an expanding base of trained endoscopists and surgeons are driving interest in cost-efficient technologies and scalable training models. Manufacturing and assembly footprints in this region also act as strategic anchors for companies seeking to diversify supply chains and reduce exposure to import tariffs, while local clinical studies and partnerships with regional opinion leaders can meaningfully influence adoption.

Key company-level insights highlighting how platform strategies, partnerships, clinical evidence, and aftermarket services determine competitive advantage in the GERD devices market

Competitive dynamics in the gastroesophageal reflux disease device arena are influenced by a mix of established medical device organizations, specialized emerging firms, and cross-sector technology partners focused on platform scalability and clinical integration. Leading players are investing in modular platform strategies that enable incremental feature upgrades without wholesale reinvention of hardware, thereby shortening product iteration cycles while managing regulatory burden. Concurrently, smaller innovators are carving niche positions by solving specific clinical pain points such as device profile reduction, simplified deployment, or improved post-procedure monitoring.

Strategic partnerships and selective acquisitions are common as companies seek to combine clinical credibility with commercialization scale, and aftermarket services-such as procedural training, proctoring, and disposable consumable programs-are increasingly important revenue and retention levers. Intellectual property portfolios and the depth of clinical evidence are crucial differentiators that influence hospital formulary decisions and payer discussions. Finally, companies that integrate digital health capabilities, patient-reported outcome tracking, and remote follow-up tools are more likely to secure long-term contracts with health systems seeking comprehensive care pathways rather than standalone devices.

Targeted and practical recommendations for leaders to fortify supply chains, evidence generation, training programs, and commercial models to accelerate adoption and protect margin

Industry leaders should prioritize a set of practical, execution-focused actions to navigate current headwinds and capture emerging opportunities. First, diversify component sourcing and consider nearshoring critical subassembly processes to mitigate tariff exposure and reduce lead-time variability. Parallel to supply chain resilience, invest in clinical evidence generation that aligns with payer endpoints and hospital value frameworks, focusing on durability, quality-of-life measures, and cost-offset analyses that support adoption across ambulatory and hospital settings.

Second, design training and proctoring programs that lower the procedural learning curve and enable rapid scale within ambulatory surgical centers and specialty clinics, thereby expanding addressable use cases. Third, adopt flexible commercial models that combine direct sales for high-touch conversions with expanded e-commerce and distributor partnerships for consumables and adjuncts, while negotiating bundled pricing or subscription approaches that align incentives with long-term outcomes. Fourth, accelerate development of next generation device features such as MRI-safe materials, adjustable magnetic constructs, and advanced catheter control to differentiate product roadmaps. Fifth, engage proactively with regulators and payers to streamline coverage pathways and to influence clinical guideline inclusion. Finally, implement scenario planning for tariff shifts and reimbursement changes to ensure pricing agility and to preserve investments in R&D and clinician engagement.

A transparent and rigorous research methodology combining primary clinician and procurement interviews with secondary clinical and regulatory synthesis and supply chain mapping

The research methodology underpinning this analysis combines structured primary inquiry with rigorous secondary synthesis and iterative validation to ensure credibility and actionable relevance. Primary research involved structured interviews with clinicians, procurement leaders, supply chain managers, and industry executives to capture real-world device performance, adoption barriers, and procurement preferences. Secondary research included systematic review of peer-reviewed clinical literature, regulatory filings, procedure coding guidelines, and publicly available technology briefs to map device feature sets and clinical endpoints.

Data triangulation was applied by cross-referencing interview insights with regulatory documentation and manufacturer technical specifications. Supply chain mapping leveraged trade flows, component sourcing patterns, and manufacturing footprint analyses to interpret tariff impacts and logistical constraints. Quality control measures included peer review by clinical experts and methodologists, reconciliation of divergent viewpoints, and transparent documentation of assumptions. Limitations are acknowledged where regional data gaps exist or where long-term durability evidence is still maturing, and the report recommends periodic updates as additional real-world evidence and regulatory decisions become available.

Concluding synthesis emphasizing the imperative to align clinical evidence, supply chain resilience, and adaptive commercialization to lead in GERD device adoption

In summary, the gastroesophageal reflux disease device market is at an inflection point driven by technological refinement, procedural migration to ambulatory settings, and evolving payer expectations. Manufacturers that align product development with demonstrable clinical value, invest in robust training and aftercare programs, and build resilient supply chains will be best positioned to capitalize on the shift toward minimally invasive and outpatient-centric care pathways. The cumulative tariff environment and regional regulatory heterogeneity add complexity, but they also create incentives for onshoring and strategic partnerships that can yield competitive advantage.

Ultimately, success will hinge on the ability to translate clinical promise into reproducible outcomes, to present clear value propositions to payers and providers, and to execute adaptable commercial models that reflect the operational realities of ambulatory surgical centers, clinics, and hospitals. Stakeholders who combine clinical rigor, supply chain foresight, and customer-centric commercialization will lead the next wave of adoption and shape long-term standards of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of magnetic sphincter augmentation devices as an alternative to long-term PPI therapy
  • 5.2. Integration of real-time impedance-pH monitoring catheters with wireless data analytics for personalized reflux management
  • 5.3. Development of transoral incisionless fundoplication systems with enhanced endoscopic suturing capabilities
  • 5.4. Expansion of biodegradable stent technologies to minimize complications in refractory GERD patients
  • 5.5. Impact of remote patient monitoring platforms on long-term outcomes in post-fundoplication GERD treatment
  • 5.6. Efficacy of emerging acid pocket targeting technologies using novel ultrasound-guided balloon systems
  • 5.7. Growth of patient-centric digital health applications for symptom tracking and AI-driven treatment recommendations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroesophageal Reflux Disease Devices Market, by Product Type

  • 8.1. Endoscopic Suturing Devices
    • 8.1.1. Competitor Suturing Systems
    • 8.1.2. Overstitch Systems
  • 8.2. Magnetic Sphincter Augmentation Devices
    • 8.2.1. First Generation Systems
    • 8.2.2. Next Generation Systems
  • 8.3. Radiofrequency Ablation Devices
    • 8.3.1. Advanced Catheter Systems
    • 8.3.2. Standard Catheter Systems
  • 8.4. Surgical Fundoplication Devices
    • 8.4.1. Conventional Laparoscopic Systems
    • 8.4.2. Robotic Assisted Laparoscopic Systems
  • 8.5. Transoral Incisionless Fundoplication Devices
    • 8.5.1. Esophyx Systems
    • 8.5.2. Next Generation Fundoplication Systems

9. Gastroesophageal Reflux Disease Devices Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Freestanding Centers
    • 9.1.2. Hospital Affiliated Centers
  • 9.2. Clinics
    • 9.2.1. Primary Care Clinics
    • 9.2.2. Specialty Clinics
  • 9.3. Hospitals
    • 9.3.1. General Hospitals
    • 9.3.2. Specialty Centers
      • 9.3.2.1. Gastroenterology Specialty Centers
      • 9.3.2.2. Multispecialty Centers

10. Gastroesophageal Reflux Disease Devices Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Online Sales
    • 10.2.1. E Commerce Platforms
    • 10.2.2. Manufacturer Portals
  • 10.3. Third Party Distributors
    • 10.3.1. National Distributors
    • 10.3.2. Regional Distributors

11. Gastroesophageal Reflux Disease Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Gastroesophageal Reflux Disease Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Gastroesophageal Reflux Disease Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Johnson & Johnson
    • 14.3.2. Medtronic plc
    • 14.3.3. Boston Scientific Corporation
    • 14.3.4. Olympus Corporation
    • 14.3.5. Becton, Dickinson and Company
    • 14.3.6. Cook Medical LLC
    • 14.3.7. Torax Medical, Inc.
    • 14.3.8. Mederi Therapeutics, Inc.
    • 14.3.9. EndoGastric Solutions, Inc.
    • 14.3.10. GI Dynamics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES M